Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
26.54
+0.37 (1.41%)
At close: Nov 21, 2024, 4:00 PM
26.78
+0.24 (0.90%)
After-hours: Nov 21, 2024, 6:06 PM EST
Immunovant Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2018 |
| Cash & Equivalents | 472.94 | 635.37 | 376.53 | 493.82 | 400.15 | 100.57 | Upgrade
|
| Cash & Short-Term Investments | 472.94 | 635.37 | 376.53 | 493.82 | 400.15 | 100.57 | Upgrade
|
| Cash Growth | 75.21% | 68.74% | -23.75% | 23.41% | 297.87% | 1339.81% | Upgrade
|
| Accounts Receivable | 1.88 | 5.34 | 0.7 | 12.23 | 0.6 | - | Upgrade
|
| Other Receivables | - | 0.17 | 0.19 | 0.63 | 0.55 | 3.05 | Upgrade
|
| Receivables | 1.88 | 5.5 | 0.89 | 12.86 | 1.14 | 3.05 | Upgrade
|
| Prepaid Expenses | 32.56 | 24.9 | 26.92 | 6.25 | 7.72 | 5.46 | Upgrade
|
| Total Current Assets | 507.37 | 665.77 | 404.33 | 512.93 | 409.01 | 109.08 | Upgrade
|
| Property, Plant & Equipment | 0.72 | 0.6 | 1.51 | 2.63 | 3.48 | 0.07 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | - | 0.25 | Upgrade
|
| Total Assets | 515.71 | 666.37 | 405.84 | 515.56 | 412.49 | 109.39 | Upgrade
|
| Accounts Payable | 20.73 | 7.16 | 1.35 | 18.63 | 2.43 | 1.19 | Upgrade
|
| Accrued Expenses | 45.88 | 41.3 | 40.42 | 24.58 | 15.16 | 10.94 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 3.19 | Upgrade
|
| Current Portion of Leases | 0.05 | 0.14 | 1.17 | 1.15 | 1.18 | - | Upgrade
|
| Other Current Liabilities | - | 0.02 | 0.35 | 0.17 | - | - | Upgrade
|
| Total Current Liabilities | 66.65 | 48.61 | 43.3 | 44.52 | 18.77 | 15.32 | Upgrade
|
| Long-Term Leases | - | - | 0.05 | 1.22 | 2.24 | - | Upgrade
|
| Total Liabilities | 66.65 | 48.61 | 43.34 | 45.74 | 21.01 | 15.32 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,469 | 1,442 | 927.98 | 824.8 | 590.43 | 185.31 | Upgrade
|
| Retained Earnings | -1,022 | -825.68 | -566.35 | -355.39 | -198.66 | -91.23 | Upgrade
|
| Comprehensive Income & Other | 1.91 | 1.91 | 0.85 | 0.4 | -0.3 | -0.02 | Upgrade
|
| Shareholders' Equity | 449.05 | 617.76 | 362.49 | 469.83 | 391.48 | 94.07 | Upgrade
|
| Total Liabilities & Equity | 515.71 | 666.37 | 405.84 | 515.56 | 412.49 | 109.39 | Upgrade
|
| Total Debt | 0.05 | 0.14 | 1.22 | 2.36 | 3.42 | 3.19 | Upgrade
|
| Net Cash (Debt) | 472.89 | 635.23 | 375.31 | 491.45 | 396.73 | 97.38 | Upgrade
|
| Net Cash Growth | 75.59% | 69.25% | -23.63% | 23.88% | 307.40% | 1294.14% | Upgrade
|
| Net Cash Per Share | 3.24 | 4.60 | 3.05 | 4.48 | 4.52 | 2.25 | Upgrade
|
| Filing Date Shares Outstanding | 146.78 | 146.05 | 130.41 | 116.51 | 97.98 | 80.91 | Upgrade
|
| Total Common Shares Outstanding | 146.57 | 145.58 | 130.33 | 116.48 | 97.97 | 54.66 | Upgrade
|
| Working Capital | 440.72 | 617.16 | 361.04 | 468.41 | 390.24 | 93.76 | Upgrade
|
| Book Value Per Share | 3.06 | 4.24 | 2.78 | 4.03 | 4.00 | 1.72 | Upgrade
|
| Tangible Book Value | 449.05 | 617.76 | 362.49 | 469.83 | 391.48 | 94.07 | Upgrade
|
| Tangible Book Value Per Share | 3.06 | 4.24 | 2.78 | 4.03 | 4.00 | 1.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.